DAVID R. LANGLEY,HAROLD MASTALERZ,MARK D. WITTMAN,KURT ZIMMERMANN,MARK G. SAULNIER,UPENDER VELAPARTHI,DOLATRAI M VYAS,GUIFEN ZHANG,WALTER LEWIS JOHNSON,DAVID B. FRENNESSON,XIAOPENG SANG,PEIYING LIU
申请号:
PT07799265
公开号:
PT2041138E
申请日:
2007.07.03
申请国别(地区):
PT
年份:
2014
代理人:
摘要:
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.